JACQUELYN MCGINNESS: Open Payments
NPI 1699856393 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 14 payments from 8 companies in 2025. Trend: 2023 $294 · 2024 $331 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $143 |
| Galderma Laboratories, L.P. | 3 | $60 |
| ABBVIE INC. | 2 | $45 |
| Incyte Corporation | 2 | $40 |
| GENZYME CORPORATION | 1 | $28 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Rhapsido, COSENTYX, NEMLUVIO, OPZELURA, DUPIXENT, SKYRIZI, Zoryve, RINVOQ.
Industry payments across MN — which companies pay providers there.
